Concourse Financial Group Securities’s Alzamend Neuro ALZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 289 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 2446 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 2438 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 2493 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 2501 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 2466 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 2494 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 2513 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 2538 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 2478 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 2207 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 2354 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 2322 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 2519 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 2545 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 2499 |
|